Assessment of Vedolizumab Disease‐Drug‐Drug Interaction Potential in Patients With Inflammatory Bowel Diseases-Reference-Cited by-同舟云学术

Assessment of Vedolizumab Disease‐Drug‐Drug Interaction Potential in Patients With Inflammatory Bowel Diseases

Published:2020-12-16 Issue: Volume: Page:
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Sun Wan¹,Lirio Richard A.¹,Schneider Jennifer²,Aubrecht Jiri¹,Kadali Harisha¹,Baratta Mike¹,Gulati Parul¹,Suri Ajit¹,Lin Tiffany²,Vasudevan Raghavan¹,Rosario Maria¹

Affiliation:

1. Takeda Cambridge Massachusetts USA

2. Certara USA, Inc. Princeton New Jersey USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.891

Reference51 articles.

1. Assessment of Disease‐Related Therapeutic Protein Drug‐Drug Interaction for Etrolizumab in Patients With Moderately to Severely Active Ulcerative Colitis

2. CYP-Mediated Therapeutic Protein-Drug Interactions

3. Impact of Infectious and Inflammatory Disease on Cytochrome P450–Mediated Drug Metabolism and Pharmacokinetics

4. REGULATION OF DRUG-METABOLIZING ENZYMES AND TRANSPORTERS IN INFLAMMATION

5. Effects of IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rosa Roxburghii Tratt Fruit Extract Prevents Dss-Induced Ulcerative Colitis in Mice by Modulating the Gut Microbiota and the IL-17 Signaling Pathway;Nutrients;2023-10-27

2. The Role of CYP3A in Health and Disease;Biomedicines;2022-10-24

3. Risk assessment of drug–drug interaction potential for bintrafusp alfa with cytochrome P4503A4 substrates: A totality of evidence approach;Clinical and Translational Science;2022-10-06

4. Not your usual drug‐drug interactions: Monoclonal antibody–based therapeutics may interact with antiseizure medications;Epilepsia;2021-12-29